Abstract
Right ventricular outflow tract (RVOT) reconstruction is becoming more prevalent as the number of adult patients who require repeated surgery long after definitive repair of congenital heart defects during childhood has increased. Early primary repair and annulus-preserving surgery have been the two current strategies of RVOT reconstruction from the viewpoint of timing and indications for surgical intervention; however, the long-term outcomes of both procedures remain unknown. Although various materials have been used for pulmonary valve replacement during RVOT reconstruction, deficient durability due primarily to immunological rejection frequently arises, particularly when implanted into young patients. A multicenter study in Japan showed that the clinical outcomes of expanded polytetrafluoroethylene (ePTFE) valved patches/conduits that we developed and manufactured comprised an excellent alternative material for RVOT reconstruction. Such enhanced outcomes might have partly been attributable to the biocompatibility and low antigenicity of ePTFE, and also to the fluid dynamic properties arising from the structural characteristics of a bulging sinus and a fan-shaped valve. However, numerous issues concerning RVOT reconstruction, such as indications for and the timing of definitive repair, as well as the choice of materials for pulmonary valve replacement, must be resolved to achieve better patient prognoses and quality of life. This review describes recent surgical strategies and outstanding issues associated with RVOT reconstruction.
Similar content being viewed by others
References
Warnes CA, Liberthson R, Danielson GK, Dore A, Harris L, Hoffman JI, et al. Task force 1: the changing profile of congenital heart disease in adult life. J Am Coll Cardiol. 2001;37:1170–5.
Babu-Narayan SV. Ventricular fibrosis suggested by cardiovascular magnetic resonance in adults with repaired tetralogy of fallot and its relationship to adverse markers of clinical outcome. Circulation. 2006;113:405–13.
Wessel HU, Paul MH. Exercise studies in tetralogy of Fallot: a review. Pediatr Cardiol. 1999;20:39–47.
Gatzoulis MA, Balaji S, Webber SA, Siu SC, Hokanson JS, Poile C, et al. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study. Lancet. 2000;356:975–81.
Schamberger MS, Hurwitz RA. Course of right and left ventricular function in patients with pulmonary insufficiency after repair of tetralogy of fallot. Pediatr Cardiol. 2000;21:244–8.
Broberg CS, Aboulhosn J, Mongeon F-P, Kay J, Valente AM, Khairy P, et al. Prevalence of left ventricular systolic dysfunction in adults with repaired tetralogy of fallot. Am J Cardiol. 2011;107:1215–20.
Davlouros PA, Kilner PJ, Hornung TS, Li W, Francis JM, Moon JCC, et al. Right ventricular function in adults with repaired tetralogy of Fallot assessed with cardiovascular magnetic resonance imaging: detrimental role of right ventricular outflow aneurysms or akinesia and adverse right-to-left ventricular interaction. J Am Coll Cardiol. 2002;40:2044–52.
Davlouros PA, Karatza AA, Gatzoulis MA, Shore DF. Timing and type of surgery for severe pulmonary regurgitation after repair of tetralogy of Fallot. Int J Cardiol. 2004;97:91–101.
Singh GK, Greenberg SB, Yap YS, Delany DP, Keeton BR, Monro JL. Right ventricular function and exercise performance late after primary repair of tetralogy of Fallot with the transannular patch in infancy. Am J Cardiol. 1998;81:1378–82.
Uebing A, Fischer G, Bethge M, Scheewe J, Schmiel F, Stieh J, et al. Influence of the pulmonary annulus diameter on pulmonary regurgitation and right ventricular pressure load after repair of tetralogy of Fallot. Heart. 2002;88:510–4.
Parry AJ, McElhinney DB, Kung GC, Reddy VM, Brook MM, Hanley FL. Elective primary repair of acyanotic tetralogy of Fallot in early infancy: overall outcome and impact on the pulmonary valve. J Am Coll Cardiol. 2000;36:2279–83.
Latus H, Gummel K, Rupp S, Valeske K, Akintuerk H, Jux C, et al. Beneficial effects of residual right ventricular outflow tract obstruction on right ventricular volume and function in patients after repair of tetralogy of Fallot. Pediatr Cardiol. 2013;34:424–30.
van der Hulst AE, Hylkema MG, Vliegen HW, Delgado V, Hazekamp MG, Rijlaarsdam MEB, et al. Mild residual pulmonary stenosis in tetralogy of Fallot reduces risk of pulmonary valve replacement. Ann Thorac Surg. 2012;94:2077–82.
Stewart RD, Backer CL, Young L, Mavroudis C. Tetralogy of Fallot: results of a pulmonary valve-sparing strategy. Ann Thorac Surg. 2005;80:1431–9.
Boni L, García E, Galletti L, Pérez A, Herrera D, Ramos V, et al. Current strategies in tetralogy of Fallot repair: pulmonary valve sparing and evolution of right ventricle/left ventricle pressures ratio. Eur J Cardiothorac Surg. 2009;35:885–90.
Gladman G, McCrindle BW, Williams WG, Freedom RM, Benson LN. The modified Blalock-Taussig shunt: clinical impact and morbidity in Fallot’s tetralogy in the current era. J Thorac Cardiovasc Surg. 1997;114:25–30.
Hirsch JC, Mosca RS, Bove EL. Complete repair of tetralogy of Fallot in the neonate: results in the modern era. Ann Surg. 2000;232:508–14.
Bacha EA, Scheule AM, Zurakowski D, Erickson LC, Hung J, Lang P, et al. Long-term results after early primary repair of tetralogy of Fallot. J Thorac Cardiovasc Surg. 2001;122:154–61.
Pigula FA, Khalil PN, Mayer JE, del Nido PJ, Jonas RA. Repair of tetralogy of Fallot in neonates and young infants. Circulation. 1999;100(Suppl2)(2):II157–61.
Tamesberger MI, Lechner E, Mair R, Hofer A, Sames-Dolzer E, Tulzer G. Early primary repair of tetralogy of Fallot in neonates and infants less than four months of age. Ann Thorac Surg. 2008;86:1928–35.
Steiner MB, Tang X, Gossett JM, Malik S, Prodhan P. Timing of complete repair of non–ductal-dependent tetralogy of Fallot and short-term postoperative outcomes, a multicenter analysis. J Thorac Cardiovasc Surg. 2014;147:1299–305.
Hayes CJ, Gersony WM, Driscoll DJ, Keane JF, Kidd L, O’Fallon WM, et al. Second natural history study of congenital heart defects. Results of treatment of patients with pulmonary valvular stenosis. Circulation. 1993;87(Suppl):I28–37.
Oechslin EN, Harrison DA, Harris L, Downar E, Webb GD, Siu SS, et al. Reoperation in adults with repair of tetralogy of Fallot: indications and outcomes. J Thorac Cardiovasc Surg. 1999;118:245–51.
Knauth AL, Gauvreau K, Powell AJ, Landzberg MJ, Walsh EP, Lock JE, et al. Ventricular size and function assessed by cardiac MRI predict major adverse clinical outcomes late after tetralogy of Fallot repair. Heart. 2008;94:211–6.
Discigil B, Dearani JA, Puga FJ, Schaff HV, Hagler DJ, Warnes CA, et al. Late pulmonary valve replacement after repair of tetralogy of Fallot. J Thorac Cardiovasc Surg. 2001;121:344–51.
van Huysduynen BH. Reduction of QRS duration after pulmonary valve replacement in adult Fallot patients is related to reduction of right ventricular volume. Eur Heart J. 2005;26:928–32.
Therrien J, Provost Y, Merchant N, Williams W, Colman J, Webb G. Optimal timing for pulmonary valve replacement in adults after tetralogy of Fallot repair. Am J Cardiol. 2005;95:779–82.
Oosterhof T, van Straten A, Vliegen HW, Meijboom FJ, van Dijk APJ, Spijkerboer AM, et al. Preoperative thresholds for pulmonary valve replacement in patients with corrected tetralogy of Fallot using cardiovascular magnetic resonance. Circulation. 2007;116:545–51.
Dave HH, Buechel ERV, Dodge-Khatami A, Kadner A, Rousson V, Bauersfeld U, et al. Early insertion of a pulmonary valve for chronic regurgitation helps restoration of ventricular dimensions. Ann Thorac Surg. 2005;80:1615–21.
Tweddell JS, Simpson P, Li SH, Dunham-Ingle J, Bartz PJ, Earing MG, et al. Timing and technique of pulmonary valve replacement in the patient with tetralogy of Fallot. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2012;15:27–33.
Harrild DM, Berul CI, Cecchin F, Geva T, Gauvreau K, Pigula F, et al. Pulmonary valve replacement in tetralogy of Fallot: impact on survival and ventricular tachycardia. Circulation. 2009;119:445–51.
Urso S, Rega F, Meuris B, Gewillig M, Eyskens B, Daenen W, et al. The Contegra conduit in the right ventricular outflow tract is an independent risk factor for graft replacement. Eur J Cardiothorac Surg. 2011;40:603–9.
Christenson JT, Sierra J, Manzano NEC, Jolou J, Beghetti M, Kalangos A. Homografts and xenografts for right ventricular outflow tract reconstruction: long-term results. Ann Thorac Surg. 2010;90(4):1287–93.
Lange R, Weipert J, Homann M, Mendler N, Paek SU, Holper K, et al. Performance of allografts and xenografts for right ventricular outflow tract reconstruction. Ann Thorac Surg. 2001;71(5 Suppl):S365–7.
Sinzobahamvya N, Wetter J, Blaschczok HC, Cho MY, Brecher AM, Urban AE. The fate of small-diameter homografts in the pulmonary position. Ann Thorac Surg. 2001;72:2070–6.
Askovich B, Hawkins JA, Sower CT, Minich LL, Tani LY, Stoddard G, et al. Right ventricle–to–pulmonary artery conduit longevity: is it related to allograft size? Ann Thorac Surg. 2007;84:907–12.
Karamlou T, Blackstone EH, Hawkins JA, Jacobs ML, Kanter KR, Brown JW, et al. Can pulmonary conduit dysfunction and failure be reduced in infants and children less than age 2 years at initial implantation? J Thorac Cardiovasc Surg. 2006;132(829–838):e5.
Vogt PR, Stallmach T, Niederhäuser U, Schneider J, Zünd G, Lachat M, et al. Explanted cryopreserved allografts: a morphological and immunohistochemical comparison between arterial allografts and allograft heart valves from infants and adults. Eur J Cardiothorac Surg. 1999;15:639–44.
Rajani B, Mee RB, Ratliff NB. Evidence for rejection of homograft cardiac valves in infants. J Thorac Cardiovasc Surg. 1998;115:111–7.
Konuma T, Devaney EJ, Bove EL, Gelehrter S, Hirsch JC, Tavakkol Z, et al. Performance of cryovalve SG decellularized pulmonary allografts compared with standard cryopreserved allografts. Ann Thorac Surg. 2009;88:849–55.
Ruzmetov M, Shahh JJ, Geiss DM, Fortuna RS. Decellularized versus standard cryopreserved valve allografts for right ventricular outflow tract reconstruction: a single-institution comparison. J Thorac Cardiovasc Surg. 2012;143:543–9.
Kadoba K, Armiger LC, Sawatari K, Jonas RA. Mechanical durability of pulmonary allograft conduits at systemic pressure. Angiographic and histologic study in lambs. J Thorac Cardiovasc Surg. 1993;105:132–41.
DeLeon SY, Tuchek JM, Bell TJ, Hofstra J, Vitullo DA, Quinones JA, et al. Early pulmonary homograft failure from dilatation due to distal pulmonary artery stenosis. Ann Thorac Surg. 1996;61:234–6.
Protopapas AD, Athanasiou T. Contegra conduit for reconstruction of the right ventricular outflow tract: a review of published early and mid-time results. J Cardiothorac Surg. 2008;3:62.
Iyer KS. The Contegra bovine jugular valved conduit: living up to expectations? Ann Pediatr Cardiol. 2012;5:34–5.
Dave H, Mueggler O, Comber M, Enodien B, Nikolaou G, Bauersfeld U, et al. Risk factor analysis of 170 single-institutional contegra implantations in pulmonary position. Ann Thorac Surg. 2011;91:195–203.
Breymann T, Blanz U, WOJTALIK M, Daenen W, Hetzer R, Sarris G, et al. European contegra multicentre study: 7-year results after 165 valved bovine jugular vein graft implantations. Thorac Cardiovasc Surg. 2009;57:257–69.
Prior N, Alphonso N, Arnold P, Peart I, Thorburn K, Venugopal P, et al. Bovine jugular vein valved conduit: up to 10 years follow-up. J Thorac Cardiovasc Surg. 2011;141:983–7.
Göber V, Berdat P, Pavlovic M, Pfammatter J-P, Carrel TP. Adverse mid-term outcome following RVOT reconstruction using the contegra valved bovine jugular vein. Ann Thorac Surg. 2005;79:625–31.
Meyns B, Van Garsse L, Boshoff D, Eyskens B, Mertens L, Gewillig M, et al. The Contegra conduit in the right ventricular outflow tract induces supravalvular stenosis. J Thorac Cardiovasc Surg. 2004;128:834–40.
Schoenhoff FS, Loup O, Gahl B, Banz Y, Pavlovic M, Pfammatter J-P, et al. The Contegra bovine jugular vein graft versus the Shelhigh pulmonic porcine graft for reconstruction of the right ventricular outflow tract: a comparative study. J Thorac Cardiovasc Surg. 2011;141:654–61.
Wojtalik M, Mrowczynski W, Eromski J, Bartkowski R. Does contegra xenograft implantation evoke cellular immunity in children? Interact CardioVasc Thorac Surg. 2003;2:273–8.
Tiete AR, Sachweh JS, Roemer U, Kozlik-Feldmann R, Reichart B, Daebritz SH. Right ventricular outflow tract reconstruction with the Contegra bovine jugular vein conduit: a word of caution. Ann Thorac Surg. 2004;77:2151–6.
Bautista-Hernandez V, Kaza AK, Benavidez OJ, Pigula FA. True aneurysmal dilatation of a contegra conduit after right ventricular outflow tract reconstruction: a novel mechanism of conduit failure. Ann Thorac Surg. 2008;86:1976–7.
Shebani S, Mcguirk S, Baghai M, Stickley J, Degiovanni J, Bulock F, et al. Right ventricular outflow tract reconstruction using Contegra® valved conduit: natural history and conduit performance under pressure. Eur J Cardiothorac Surg. 2006;29:397–405.
Boudjemline Y, Bonnet D, Massih TA, Agnoletti G, Iserin F, Jaubert F, et al. Use of bovine jugular vein to reconstruct the right ventricular outflow tract: early results. J Thorac Cardiovasc Surg. 2003;126:490–7.
Ishizaka T, Ohye RG, Goldberg CS, Ramsburg SR, Suzuki T, Devaney EJ, et al. Premature failure of small-sized Shelhigh no-react porcine pulmonic valve conduit model NR-4000. Eur J Cardiothorac Surg. 2003;23:715–8.
Manji RA. Glutaraldehyde-fixed bioprosthetic heart valve conduits calcify and fail from xenograft rejection. Circulation. 2006;114:318–27.
Human P, Zilla P. Characterization of the immune response to valve bioprostheses and its role in primary tissue failure. Ann Thorac Surg. 2001;71(5 Suppl):S385–8.
Manji RA, Menkis AH, Cooper DK. Porcine bioprosthetic heart valves: the next generation. Am Heart J. 2012;164:177–85.
Ilbawi MN, Lockhart CG, Idriss FS, DeLeon SY, Muster AJ, Duffy CE, et al. Experience with St. Jude Medical valve prosthesis in children. A word of caution regarding right-sided placement. J Thorac Cardiovasc Surg. 1987;93:73–9.
Fleming WH, Sarafian LB, Moulton AL, Robinson LA, Kugler JD. Valve replacement in the right side of the heart in children: long-term follow-up. Ann Thorac Surg. 1989;48:404–8.
Waterbolk T, Hoendermis E, Denhamer I, Ebels T. Pulmonary valve replacement with a mechanical prosthesis. Promising results of 28 procedures in patients with congenital heart disease. Eur J Cardiothorac Surg. 2006;30:28–32.
Stulak JM, Dearani JA, Burkhart HM, Connolly HM, Warnes CA, Suri RM, et al. The increasing use of mechanical pulmonary valve replacement over a 40-year period. Ann Thorac Surg. 2010;90:2009–15.
Shin HJ, Kim Y-H, Ko J-K, Park I-S, Seo DM. Outcomes of mechanical valves in the pulmonic position in patients with congenital heart disease over a 20-year period. Ann Thorac Surg. 2013;95:1367–71.
Dos L, Muñoz-Guijosa C, Mendez AB, Ginel A, Montiel J, Padro JM, et al. Long term outcome of mechanical valve prosthesis in the pulmonary position. Int J Cardiol. 2011;150:173–6.
Lurz P, Gaudin R, Taylor AM, Bonhoeffer P. Percutaneous pulmonary valve implantation. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2009;12:112–7.
Kenny D, Hijazi ZM, Kar S, Rhodes J, Mullen M, Makkar R, et al. Percutaneous Implantation of theEdwards SAPIEN Transcatheter Heart Valvefor Conduit Failure in the Pulmonary Position. J Am Coll Cardiol. Elsevier Inc; 2011; 58: 2248–56.
Guccione P, Milanesi O, Hijazi ZM, Pongiglione G. Transcatheter pulmonary valve implantation in native pulmonary outflow tract using the Edwards SAPIEN transcatheter heart valve. Eur J Cardiothorac Surg. 2012;41:1192–4.
Lurz P, Coats L, Khambadkone S, Nordmeyer J, Boudjemline Y, Schievano S, et al. Percutaneous pulmonary valve implantation: impact of evolving technology and learning curve on clinical outcome. Circulation. 2008;117:1964–72.
McElhinney DB, Hellenbrand WE, Zahn EM, Jones TK, Cheatham JP, Lock JE, et al. Short- and medium-term outcomes after transcatheter pulmonary valve placement in the expanded multicenter US melody valve trial. Circulation. 2010;122:507–16.
Biermann D, Schönebeck J, Rebel M, Weil J, Dodge-Khatami A. Left coronary artery occlusion after percutaneous pulmonary valve implantation. Ann Thorac Surg. 2012;94(1):e7–9.
Turrentine MW, McCarthy RP, Vijay P, McConnell KW, Brown JW. PTFE monocusp valve reconstruction of the right ventricular outflow tract. Ann Thorac Surg. 2002;73:871–9.
Izutani H, Gundry SR, Vricella LA, Xu H, Bailey LL. Right ventricular outflow tract reconstruction using a Goretex membrane monocusp valve in infant animals. ASAIO J. 2000;46:553–5.
Miyazaki T, Yamagishi M, Nakashima A, Fukae K, Nakano T, Yaku H, et al. Expanded polytetrafluoroethylene valved conduit and patch with bulging sinuses in right ventricular outflow tract reconstruction. J Thorac Cardiovasc Surg. 2007;134:327–32.
Miyazaki T, Yamagishi M, Maeda Y, Yamamoto Y, Taniguchi S, Sasaki Y, et al. Expanded polytetrafluoroethylene conduits and patches with bulging sinuses and fan-shaped valves in right ventricular outflow tract reconstruction: multicenter study in Japan. J Thorac Cardiovasc Surg. 2011;142:1122–9.
Suzuki I, Shiraishi Y, Yabe S, Tsuboko Y, Sugai TK, Matsue K, et al. Engineering analysis of the effects of bulging sinuses in a newly designed pediatric pulmonary heart valve on hemodynamic function. J Artif Organs. 2012;15:49–56.
Yamamoto Y, Yamagishi M, Miyazaki T. Right ventricular outflow tract reconstruction–rationale for the advantage of expanded polytetrafluoroethylene conduit with bulging sinuses and fan-shaped valves–. Pediatr Cardiol and Cardiac Surg. 2012;28:295–305.
Katayama S, Umetani N, Sugiura S, Hisada T. The sinus of Valsalva relieves abnormal stress on aortic valve leaflets by facilitating smooth closure. J Thorac Cardiovasc Surg. 2008;136:1528–35.
Stein PD, Sabbah HN. Measured turbulence and its effect on thrombus formation. Circ Res. 1974;35:608–14.
Sakamoto Y, Hashimoto K, Okuyama H, Ishii S, Shingo T, Kagawa H. Prevalence of pannus formation after aortic valve replacement: clinical aspects and surgical management. J Artif Organs. 2006;9:199–202.
Niwaya K, Knott-Craig CJ, Lane MM, Chandrasekaren K, Overholt ED, Elkins RC. Cryopreserved homograft valves in the pulmonary position: risk analysis for intermediate-term failure. J Thorac Cardiovasc Surg. 1999;117:141–6.
Gerestein CG, Takkenberg JJ, Oei FB, Cromme-Dijkhuis AH, Spitaels SE, van Herwerden LA, et al. Right ventricular outflow tract reconstruction with an allograft conduit. Ann Thorac Surg. 2001;71:911–7.
Perron J, Moran AM, Gauvreau K, del Nido PJ, Mayer JE, Jonas RA. Valved homograft conduit repair of the right heart in early infancy. Ann Thorac Surg. 1999;68:542–8.
Sekarski N, van Meir H, Rijlaarsdam MEB, Schoof PH, Koolbergen DR, Hruda J, et al. Right ventricular outflow tract reconstruction with the bovine jugular vein graft: 5 years’ experience with 133 patients. Ann Thorac Surg. 2007;84:599–605.
Lee C, Park CS, Lee CH, Kwak JG, Kim SJ, Shim WS, et al. Durability of bioprosthetic valves in the pulmonary position: long-term follow-up of 181 implants in patients with congenital heart disease. J Thorac Cardiovasc Surg. 2011;142:351–8.
Zubairi R, Malik S, Jaquiss RDB, Imamura M, Gossett J, Morrow WR. Risk factors for prosthesis failure in pulmonary valve replacement. Ann Thorac Surg. 2011;91:561–5.
Conflict of interest
The authors have no conflicts of interest to declare.
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is a complete re-iteration of a review article that was originally published in Kyobu Geka 2014;67:65–77 (in Japanese).
This review was submitted at the invitation of the editorial committee.
Rights and permissions
About this article
Cite this article
Yamamoto, Y., Yamagishi, M. & Miyazaki, T. Current status of right ventricular outflow tract reconstruction: complete translation of a review article originally published in Kyobu Geka 2014;67:65–77. Gen Thorac Cardiovasc Surg 63, 131–141 (2015). https://doi.org/10.1007/s11748-014-0500-0
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11748-014-0500-0